Johanna Wassermann

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Maxime Ronot, Mohamed Bouattour, Johanna Wassermann et al. · The Oncologist · 2014 · 151 citations · Full text

Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study

Elisé G. Kaboré, Charles Guénancia, Inês Vaz-Luís et al. · PLoS Medicine · 2019 · 70 citations · Full text

Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas

Johanna Wassermann, Marie‐Odile Bernier, Jean‐Philippe Spano et al. · The Oncologist · 2015 · 61 citations · Full text

Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series

Manuel Rodrigues, Julien Péron, Jean‐Sébastien Frenel et al. · Annals of Oncology · 2012 · 50 citations

Breast Oncology, Adjuvant Trastuzumab-based Chemotherapy, Medicine +6